ÂÜÀòÂÒÂ×

Thomas Gnielinski is an accomplished legal professional with extensive experience in the life sciences sector. Currently serving as VP Law and Associate General Counsel at BridgeBio since September 2021, Thomas previously held the position of VP Law and Chief Compliance Officer at Ambry Genetics. Earlier roles include Compliance Consultant for Operational Compliance Solutions LLC, Senior Director of Law at Alexion Pharmaceuticals, and various legal positions at Amgen, including Director of Compliance and Senior Counsel. Thomas began a legal career in Germany as an attorney at various law firms before transitioning to corporate counsel at Miltenyi Biotec. Academic credentials include a Dr. iur. in Law from The Julius Maximilians University of Würzburg.